Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 241

Showing 1-25 of 241 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 375
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2
Stefan Gahbauer, G.J. Correy, M. Schuller, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 2
Open Access | Times Cited: 87
Mechanisms and regulation of defensins in host defense
Jie Fu, Xin Zong, Mingliang Jin, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study
Carlos King Ho Wong, Kristy T. K. Lau, Ivan Chi Ho Au, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 6, pp. 683-695
Open Access | Times Cited: 45
SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development
Shilin Zhou, Panpan Lv, Mingxue Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114242-114242
Open Access | Times Cited: 42
Protein subunit vaccines: Promising frontiers against COVID-19
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 761-782
Closed Access | Times Cited: 15
Molecular architecture of coronavirus double-membrane vesicle pore complex
Yixin Huang, Tong-Yun Wang, Lijie Zhong, et al.
Nature (2024) Vol. 633, Iss. 8028, pp. 224-231
Open Access | Times Cited: 13
The role of SARS-CoV-2 accessory proteins in immune evasion
Milad Zandi, Maryam Shafaati, Davood Kalantar-Neyestanaki, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113889-113889
Open Access | Times Cited: 65
Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase
Zhonglei Wang, Liyan Yang, Xian-qing Song
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Virtual Screening of Peptide Libraries: The Search for Peptide-Based Therapeutics Using Computational Tools
Marian Vincenzi, Flavia Anna Mercurio, Marilisa Leone
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1798-1798
Open Access | Times Cited: 10
Differences and similarities between innate immune evasion strategies of human coronaviruses
Helene Hoenigsperger, Rinu Sivarajan, Konstantin M. J. Sparrer
Current Opinion in Microbiology (2024) Vol. 79, pp. 102466-102466
Open Access | Times Cited: 8
The role of the cGAS-STING signaling pathway in viral infections, inflammatory and autoimmune diseases
Mingming Wang, Yue Zhao, Juan Liu, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 10, pp. 1997-2010
Closed Access | Times Cited: 8
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies
Y.-C. Chung, Ching-Yin Lam, Pak-Hei Tan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8155-8155
Open Access | Times Cited: 8
Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective
Subhomoi Borkotoky, Debajit Dey, Zaved Hazarika
Molecular Biology Reports (2022) Vol. 50, Iss. 3, pp. 2713-2721
Open Access | Times Cited: 36
A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites
Md. Jahirul Islam, Nafisa Nawal Islam, Md. Siddik Alom, et al.
Immunobiology (2022) Vol. 228, Iss. 1, pp. 152302-152302
Open Access | Times Cited: 35
COVID-DSNet: A novel deep convolutional neural network for detection of coronavirus (SARS-CoV-2) cases from CT and Chest X-Ray images
Hatice Çatal Reis, Veysel Turk
Artificial Intelligence in Medicine (2022) Vol. 134, pp. 102427-102427
Open Access | Times Cited: 30
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
SARS-CoV-2 ORF3c impairs mitochondrial respiratory metabolism, oxidative stress, and autophagic flux
Alessandra Mozzi, Monica Oldani, Matilde Forcella, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107118-107118
Open Access | Times Cited: 19
SARS-CoV-2 envelope protein induces necroptosis and mediates inflammatory response in lung and colon cells through receptor interacting protein kinase 1
Budhadev Baral, Vaishali Saini, A Tandon, et al.
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1596-1617
Closed Access | Times Cited: 18
The oral manifestations and related mechanisms of COVID-19 caused by SARS-CoV-2 infection
Wei-Ming Lin, Feng Gao, Xia Wang, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 16
SARS-CoV-2 infection and its effects on the endocrine system
Charlotte Steenblock, Nicole Toepfner, Felix Beuschlein, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2023) Vol. 37, Iss. 4, pp. 101761-101761
Open Access | Times Cited: 16
Targeting SARS-CoV-2 Non-Structural Proteins
W.G. Tam, Ana C. Lorenzo‐Leal, Luis R. Hernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 13002-13002
Open Access | Times Cited: 16
A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2
Karen Sargsyan, Karine Mazmanian, Carmay Lim
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters
Emmanuel Margolin, Georgia Schäfer, Joel D. Allen, et al.
Frontiers in Plant Science (2023) Vol. 14
Open Access | Times Cited: 15
Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches
Yani Zhang, Guanghao Zhu, Wei Liu, et al.
Phytomedicine (2023) Vol. 114, pp. 154796-154796
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top